Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 2
2005 1
2006 1
2008 1
2009 1
2010 4
2012 1
2013 2
2014 5
2015 2
2016 3
2017 2
2018 2
2019 8
2020 3
2021 11
2022 5
2023 7
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

57 results

Results by year

Filters applied: . Clear all
Page 1
A novel treatment of diaper dermatitis in children and adults.
Dall'Oglio F, Musumeci ML, Puglisi DF, Micali G. Dall'Oglio F, et al. Among authors: musumeci ml. J Cosmet Dermatol. 2021 Apr;20 Suppl 1(Suppl 1):1-4. doi: 10.1111/jocd.14091. J Cosmet Dermatol. 2021. PMID: 33934478 Free PMC article. Clinical Trial.
Infantile psoriasis.
Janniger CK, Schwartz RA, Musumeci ML, Tedeschi A, Mirona B, Micali G. Janniger CK, et al. Among authors: musumeci ml. Cutis. 2005 Sep;76(3):173-7. Cutis. 2005. PMID: 16268259 Review.
COVID-19: The Italian experience.
Musumeci ML, Nasca MR, Micali G. Musumeci ML, et al. Clin Dermatol. 2021 May-Jun;39(3):418-423. doi: 10.1016/j.clindermatol.2021.01.013. Epub 2021 Feb 1. Clin Dermatol. 2021. PMID: 34517999 Free PMC article.
Long-term efficacy and safety of secukinumab in real life: a 240 weeks multicenter study from Southern Italy.
Dastoli S, Passante M, Loconsole F, Mortato E, Balato A, Piccolo V, Guarneri C, Macca L, Provenzano E, Valenti G, D'Amico D, Micali G, Musumeci ML, Palazzo G, Foti C, Romita P, Fabbrocini G, Megna M, Sammarra I, Bennardo L, Patruno C. Dastoli S, et al. Among authors: musumeci ml. J Dermatolog Treat. 2023 Dec;34(1):2200868. doi: 10.1080/09546634.2023.2200868. J Dermatolog Treat. 2023. PMID: 37026590 Free article.
Congenital Malalignment of the Great Toenails: A Review.
Catalfo P, Musumeci ML, Lacarrubba F, Dinotta F, Micali G. Catalfo P, et al. Among authors: musumeci ml. Skin Appendage Disord. 2018 Oct;4(4):230-235. doi: 10.1159/000484943. Epub 2018 Jan 25. Skin Appendage Disord. 2018. PMID: 30410889 Free PMC article. Review.
Inverse Psoriasis: From Diagnosis to Current Treatment Options.
Micali G, Verzì AE, Giuffrida G, Panebianco E, Musumeci ML, Lacarrubba F. Micali G, et al. Among authors: musumeci ml. Clin Cosmet Investig Dermatol. 2019 Dec 31;12:953-959. doi: 10.2147/CCID.S189000. eCollection 2019. Clin Cosmet Investig Dermatol. 2019. PMID: 32099435 Free PMC article. Review.
Brodalumab for the Treatment of Moderate-to-Severe Psoriasis: An Expert Delphi Consensus Statement.
Fargnoli MC, Bardazzi F, Bianchi L, Dapavo P, Fabbrocini G, Gisondi P, Micali G, Offidani AM, Pellacani G, Skroza N, Angileri RG, Burlando M, Campanati A, Carrera CG, Chiricozzi A, Conti A, Simone C, Di Lernia V, Errichetti E, Galluzzo M, Guarneri C, Lasagni C, Lembo S, Loconsole F, Megna M, Musumeci ML, Prignano F, Richetta AG, Trovato E, Venturini M, Peris K, Pinton PC. Fargnoli MC, et al. Among authors: musumeci ml. J Clin Med. 2023 May 18;12(10):3545. doi: 10.3390/jcm12103545. J Clin Med. 2023. PMID: 37240650 Free PMC article.
Cutaneous vascular patterns in psoriasis.
Micali G, Lacarrubba F, Musumeci ML, Massimino D, Nasca MR. Micali G, et al. Among authors: musumeci ml. Int J Dermatol. 2010 Mar;49(3):249-56. doi: 10.1111/j.1365-4632.2009.04287.x. Int J Dermatol. 2010. PMID: 20465659 Review.
Intergluteal Contour Deformity in Hidradenitis Suppurativa.
Musumeci ML, Capuzzo G, Cammisuli B, Pesce A, Micali G. Musumeci ML, et al. Acta Derm Venereol. 2019 Jan 1;99(1):109-110. doi: 10.2340/00015555-3033. Acta Derm Venereol. 2019. PMID: 30183056 Free article. No abstract available.
Guselkumab: an anti-IL-23 antibody for the treatment of moderate-to-severe plaque psoriasis.
Chiricozzi A, Costanzo A, Fargnoli MC, Malagoli P, Piaserico S, Amerio P, Argenziano G, Balato N, Bardazzi F, Bianchi L, Carrera CG, Conti A, Dapavo P, De Simone C, Loconsole F, Lo Schiavo A, Malara G, Musumeci ML, Parodi A, Peris K, Prignano F, Rongioletti F, Talamonti M, Potenza C. Chiricozzi A, et al. Among authors: musumeci ml. Eur J Dermatol. 2021 Feb 1;31(1):3-16. doi: 10.1684/ejd.2021.3965. Eur J Dermatol. 2021. PMID: 33648915 Review.
57 results